Identification of drug candidates and repurposing opportunities through compound-target interaction networks (Q38597446)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on October 2015

Language	Label	Description	Also known as
English	Identification of drug candidates and repurposing opportunities through compound-target interaction networks	scientific article published on October 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Identification of drug candidates and repurposing opportunities through compound-target interaction networks (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

object named as

Anna Cichonska

1

0 references

Tero Aittokallio

object named as

Tero Aittokallio

3

0 references

2

object named as

Juho Rousu

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

language of work or name

0 references

publication date

1 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Expert Opinion on Drug Discovery

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1333-1345

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Diagnosing the decline in pharmaceutical R&D efficiency

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Conciliating binding efficiency and polypharmacology

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug-target network

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Polypharmacology - foe or friend?

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Unveiling the role of network and systems biology in drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network approaches to drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Maximizing computational tools for successful drug discovery.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

High-throughput methods for combinatorial drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network pharmacology: the next paradigm in drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

A network view of disease and compound screening

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network systems biology for drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Best Practices for QSAR Model Development, Validation, and Exploitation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

A community effort to assess and improve drug sensitivity prediction algorithms.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Similarity-based machine learning methods for predicting drug-target interactions: a brief review

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Predicting in vitro drug sensitivity using Random Forests

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Kernelized Bayesian Matrix Factorization

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Chemogenomic approaches to infer drug-target interaction networks

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug-target interaction prediction via chemogenomic space: learning-based methods

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Comprehensive analysis of kinase inhibitor selectivity

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Navigating the kinome

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Tracking cancer drugs in living cells by thermal profiling of the proteome

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Mass spectrometry-based proteomics in preclinical drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Exploring chemical space for drug discovery using the chemical universe database

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

UniChem: a unified chemical structure cross-referencing and identifier tracking system

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Gaussian interaction profile kernels for predicting drug-target interaction

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Prediction of drug-target interactions and drug repositioning via network-based inference

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Prediction of chemical-protein interactions network with weighted network-based inference method

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Predicting drug-target interactions using restricted Boltzmann machines

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Relating protein pharmacology by ligand chemistry

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Predicting new molecular targets for known drugs

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Prediction of drug-target interaction networks from the integration of chemical and genomic spaces.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Supervised prediction of drug-target interactions using bipartite local models

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug-target interaction prediction through domain-tuned network-based inference.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug-target interaction prediction by random walk on the heterogeneous network

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug repositioning by integrating target information through a heterogeneous network model

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Drug target identification using side-effect similarity

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Identification of small molecules enhancing autophagic function from drug network analysis

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Finding the targets of a drug by integration of gene expression data with a protein interaction network

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Combining Drug and Gene Similarity Measures for Drug-Target Elucidation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Enhancing the prioritization of disease-causing genes through tissue specific protein interaction networks

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Construction and analyses of human large-scale tissue specific networks

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Understanding multicellular function and disease with human tissue-specific networks

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Elucidating Compound Mechanism of Action by Network Perturbation Analysis.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Validating therapeutic targets through human genetics

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

The support of human genetic evidence for approved drug indications

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Selecting causal genes from genome-wide association studies via functionally coherent subnetworks

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Towards structural systems pharmacology to study complex diseases and personalized medicine

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Opportunities for drug repositioning from phenome-wide association studies.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Rational drug repositioning by medical genetics.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Distribution and medical impact of loss-of-function variants in the Finnish founder population

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

RNA interference technology for anti-VEGF treatment

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Pharmacogenomics in clinical practice and drug development

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Cancer pharmacogenomics: strategies and challenges

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Toward more realistic drug-target interaction predictions

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Preclinical target validation using patient-derived cells

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

The ChEMBL bioactivity database: an update

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

DrugBank 4.0: shedding new light on drug metabolism

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

STITCH 4: integration of protein-chemical interactions with user data

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Data, information, knowledge and principle: back to metabolism in KEGG

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

PUG-SOAP and PUG-REST: web services for programmatic access to chemical information in PubChem

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

BRENDA in 2015: exciting developments in its 25th year of existence

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

DGIdb: mining the druggable genome

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Therapeutic target database update 2014: a resource for targeted therapeutics

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

ZINC: a free tool to discover chemistry for biology

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

Use of genome-wide association studies for drug repositioning

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2015.1096926

21 January 2018

SuperTarget and Matador: resources for exploring drug-target relationships

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1517/17460441.2015.1096926

Conditional UAS-targeted repression in Drosophila

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1517/17460441.2015.1096926

Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis.

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1517/17460441.2015.1096926

An Integrated Approach to Anti-Cancer Drug Sensitivity Prediction

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1517/17460441.2015.1096926

Discovery of drug mode of action and drug repositioning from transcriptional responses

1 reference

5 May 2024

https://opencitations.net/index/api/v1/references/10.1517/17460441.2015.1096926

Identifiers

10.1517/17460441.2015.1096926

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38597446&oldid=2145828895"